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for Asian Indians. Highly sensitive C Reactive Protein (Hs-CRP), a
marker of inﬂammation and of CVD risk, was also measured. The
study aims at recruiting 400 PLHIV; we present the preliminary
ﬁndings of 225 participants.
Results: Therewere63%males.Meanagewas43years, 7.5 years
mean duration sinceHIV diagnosis, and 97% initiated onART. Based
on the ATPIII, 52% (57% Males & 42% Females) and IDF 46% (49%
Males & 41 Females)met the criteria forMS. Agewas higher among
PLHIV with MS by either criteria. 40% had >3 mg/dl Hs-CRP levels,
with males (median 2.37, Q1 1.1, Q3 4.25) and females (median
2.31, Q1 1.2, Q3 4.97) similar statistically. The Hs-CRP levels were
not associated with MS categorized by ATP III or IDF criteria.
Conclusion: The overall prevalence ofMS and theHs-CRP levels
were high in this PLHIV population. With the diverse and incon-
sistent evidence globally on the CVD risk associated with MS and
Hs-CRP amongPLHIV, further research efforts are required to delin-
eate this dual burden among PLHIV.
http://dx.doi.org/10.1016/j.ijid.2016.02.583
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Background: National AIDS Control Programme was launched
in 1992 by National AIDS Control Organization for prevention and
control of HIV/AIDS in India. Viral load testing is a preferred test to
monitor treatment response of antiretroviral therapy (ART). How-
ever, for more than two decades, CD4 cell count measurements
have been used as a major marker in understanding HIV disease
progression, making important clinical decisions, and monitoring
the response to ART. In India, most of the laboratories have been
using CD4 count for monitoring the response of ART. The study is
undertaken because there is limited data available about response
to ART.
Methods&Materials:HIV caseswhopresentedat theARTclinic
of JIPMER and were on ART from September 2014 to August 2015
were included in the retrospective study. Patient demographic
details and CD 4 count were recorded. A patient on ART was con-
sidered non-responsive to the ART if the CD 4 count didn’t rise after
six month of ART regime.
Results: A total of 581 HIV positive patients presented at the
ART clinic of JIPMERduring the studyperiod. 300 (51.6%)weremale
and 281 (48.4%) were female. 448 patients (77%) were resident of
Tamil Nadu and 133 (23%) were from Pondicherry. 442 patients
(76%) were on ART and CD4 count were recorded. CD 4 count of
126 (28.5%) patients didn’t rise from their previous CD4 count and
were considerednon-responsive to theART. 69 (54.8%)were female
and 57 (45.2%) were male.
Conclusion: In resource limited settings CD4 count testing is
most commonly done to monitor the ART response in HIV positive
patients. Itwoulddetect treatment failure andsupport clinical deci-
sion for starting the patient on second line ART. 28.5% of patients on
ART didn’t observe improvement in their CD 4 count. These cases
were observed more in females (54.8%) than males (45.2%). It may
be due to due to non-compliance of ART by these patients. There is
a risk of development of HIV drug resistance in these cases. Large
scale of similar study will be required to generate broader data
which will facilitate better ART care.
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Background: During HIV infection, apart from use of PI-based
regimen, low CD4+ T-cell count has also been identiﬁed as a vas-
cular risk factor. Initiating ART in patients with higher nadir CD4
counts is speculated to better normalise CVD risks and inﬂamma-
tory response. We aimed to study effect of nadir CD4 count on CVD
and inﬂammatory response in ART naive and treated HIV patients.
Methods & Materials: Cross-sectional enrolment of 169
HIV-infected patients (68 naive; 101 ART experienced) with dif-
ferent nadir CD4 counts; Drug Naive(DN)- Group 1 (n=24;Nadir
CD4<350cells/L); Group2 (n=44;Nadir CD4>350cells/L); ART
experienced- Group 3 (n=32;Nadir CD4 <200cells/L);Group 4
(n=36;Nadir CD4 200-350cells/L);Group 5 (n=33;Nadir CD4
>350cells/L) and Group 6 (n=29 healthy controls (HC) were done.
Wemeasured serum lipid proﬁle (LP), C-IMT, cardiac output, TNFR-
1, TNFR-2 for inﬂammation, sCD14 for microbial translocation
(MT) by ELISA. Descriptive statistics were used for demographics;
ANOVA to identify differences in LP, C-IMT, cardiac output, inﬂam-
mation, MT between groups.
Results: Mean age, median current and nadir CD4 count
for groups 1-5: 37.7±5.6, 123.5(70-273.5), 123.5(70-273.5);
35.36±5.2, 534(440-595), 572(496.5-761.25); 38.7±5.7, 138.5(83-
167.5), 569(430.25-773.5); 38.3±5.9, 273.5(228.5-317.5), 717(564-
867.5); 40.3±5.1, 402(378-438), 777(649-1005); 37±5.9. C-IMT
